Download PDF
Synthesis 2000; 2000(8): 1113-1116
DOI: 10.1055/s-2000-6321
paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Total Synthesis of RS-42358 and Analogs Using Lateral Lithiation

Bruce A. Kowalczyk*
  • *Chemical Development, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, California 94304, USA; Fax +1 (6 50) 3 54 79 29; E-mail: bruce.kowalczyk@roche.com
Further Information

Publication History

Publication Date:
31 December 2000 (online)

  PDF Download  Permissions and Reprints All articles of this category

A short synthesis of the 5-HT3 receptor antagonist RS-42358 was developed based on the condensation of lactone 2 with S3-aminoquinuclidine. The position 2 analogs of RS-42358 were made by condensing various primary amines with lactone 2. The key step in the synthesis of lactone 2 was lateral lithiation of diethyl amide 7 using n-BuLi in THF.

lateral lithiation - 5-HT3 - receptor antagonist - RS-42358

      >